Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,059.50    9.50 (0.90%)
Bid:
1,058.50
Ask:
1,060.00
Spread: 1.50 (0.142%)
Market Cap: £3.40b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Director/PDMR Shareholding

19 Jun 2024 14:48

RNS Number : 1023T
Persimmon PLC
19 June 2024
 

19 June 2024

Persimmon Plc (the "Company")

Director/PDMR Shareholding

Andrew Duxbury commenced his role as Chief Financial Officer of the Company on 17 June 2024.

On 18 June 2024, Andrew's wife Rachel Duxbury purchased 3,462 shares in the Company at a price of £14.295 per share. 

Furthermore, as reported in the Company's Directors' Remuneration Report for the year ended 31 December 2023, in line with usual practice the Remuneration Committee agreed that in recognition of Andrew's forfeiture of remuneration on leaving his former employer, he would be granted buy-out awards. These have been made on the basis that any compensation due should not result in an outcome where Andrew receives more than would have been due had he remained in post at Galliford Try. Information in relation to the principles applied in agreeing the buy-out awards is included in that Directors' Remuneration Report. Details of the buy-out awards granted in shares on 18 June 2024 are summarised below.

Forfeited remuneration

Number of Persimmon shares subject to the buy-out award

Vesting date of buy-out award

2021 Deferred Bonus

12,353

23 September 2024

2022 Deferred Bonus

13,909

28 September 2025

2023 Deferred Bonus

3,998

27 September 2026

2021 LTIP

55,295

23 September 2024 (followed by a two year holding period)*

2022 LTIP

42,111

23 September 2025 (followed by a two year holding period)*

2023 LTIP

14,743

March 2026 (followed by a two and a half year holding period)**

\* The vesting of these awards is subject to the satisfaction of the performance conditions applying to the forfeited awards.

*\* The vesting of this award is subject to the satisfaction of the performance conditions applying to the Persimmon Plc PSP award granted in 2023, details of which are included in the Company's Directors' Remuneration Report for the year ended 31 December 2023.

In addition, on 18 June 2024 an award was granted to Andrew over 73,376 shares, under the Persimmon Plc 2017 Performance Share Plan. The three year performance period will run from 1 January 2024 to 31 December 2026 and there is a further two year holding period before the shares can be released. The award is subject to the same performance conditions as apply to the PSP award granted to Dean Finch on 25 March 2024 and details of which are included in the Company's 2023 Directors' Remuneration Report.

The below notification, made in accordance with the requirements of article 19.3 of the UK Market Abuse Regulation, gives further details:

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Rachel Duxbury

2

 

Reason for the notification

 

a)

 

Position/status

 

Closely associated person of Andrew Duxbury, Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Persimmon Plc

b)

 

LEI

 

213800XI72Y57UWN6F31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each

Identification code

GB0006825383

b)

 

Nature of the transaction

 

 

Purchase of shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£14.295

3,462

 

 

d)

 

Aggregated information

- Aggregated volume

N/A Single transaction

- Price

N/A Single transaction

e)

 

Date of the transaction

 

18/06/2024

f)

 

Place of the transaction

 

London Stock Exchange (XLON), Main Market

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Andrew Duxbury

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Persimmon Plc

b)

 

LEI

 

213800XI72Y57UWN6F31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each

Identification code

GB0006825383

b)

 

Nature of the transaction

 

 

Grant of award made under the 2017 Performance Share Plan subject to performance criteria

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

73,376

 

 

d)

 

Aggregated information

- Aggregated volume

N/A Single transaction

- Price

N/A Single transaction

e)

 

Date of the transaction

 

18/06/2024

f)

Place of the transaction

Outside a trading venue

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Andrew Duxbury

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer

a)

Name

Persimmon Plc

b)

LEI code

213800XI72Y57UWN6F31

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 10p each

Identification code

GB0006825383

b)

Nature of the transaction

Grant of awards over Persimmon shares in respect of remuneration forfeited on leaving previous employer.

c)

Price(s) and volume(s)

Award

Price

Volume

Award granted in respect of 2021 deferred bonus

Nil

12,353

Award granted in respect of 2022 deferred bonus

Nil

13,909

Award granted in respect of 2023 deferred bonus

Nil

3,998

Award granted in respect of 2021 LTIP

Nil

55,295

Award granted in respect of 2022 LTIP

Nil

42,111

Award granted in respect of 2023 LTIP

Nil

14,743

d)

Aggregated information

- Aggregated volume

- Price

 

142,409

Nil

e)

Date of the transaction

18 June 2024

f)

Place of the transaction

Outside a trading venue

 

Tracy Davison

Company Secretary

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEADKNFLXLEFA
Date   Source Headline
1st Jul 202610:12 amRNSAdmission to Trading
1st Jul 202610:09 amRNSTotal Voting Rights
1st Jun 202610:06 amRNSAdmission to Trading
1st Jun 202610:03 amRNSTotal Voting Rights
29th May 202611:57 amRNSDirector/PDMR Shareholding
11th May 20264:56 pmRNSHolding(s) in Company
1st May 202612:12 pmRNSAdmission to Trading
1st May 202612:06 pmRNSTotal Voting Rights
30th Apr 20262:19 pmRNSResult of AGM
30th Apr 20262:18 pmRNSHolding(s) in Company
30th Apr 20267:00 amRNSAGM Trading Statement
23rd Apr 20269:21 amRNSHolding(s) in Company
1st Apr 20261:45 pmRNSAdmission to Trading
1st Apr 20261:43 pmRNSTotal Voting Rights
30th Mar 20263:06 pmRNSDirector/PDMR Shareholding
24th Mar 20263:20 pmRNSDirector/PDMR Shareholding
23rd Mar 20262:12 pmRNSAnnual Report 2025 and Notice of AGM 2026
10th Mar 20267:00 amRNSFull Year Results
2nd Mar 202611:26 amRNSTotal Voting Rights
18th Feb 20261:33 pmRNSNew Issue of Equity Securities
2nd Feb 202610:00 amRNSTotal Voting Rights
13th Jan 20267:00 amRNS2025 Trading Statement
2nd Jan 202612:52 pmRNSTotal Voting Rights
2nd Jan 202611:09 amRNSHolding(s) in Company
30th Dec 20254:44 pmRNSHolding(s) in Company
30th Dec 20254:44 pmRNSHolding(s) in Company
24th Dec 202512:29 pmRNSHolding(s) in Company
24th Dec 202512:29 pmRNSHolding(s) in Company
22nd Dec 20252:22 pmRNSHolding(s) in Company
22nd Dec 20252:22 pmRNSHolding(s) in Company
1st Dec 20252:58 pmRNSBlock listing Interim Review
1st Dec 202512:39 pmRNSTotal Voting Rights
27th Nov 202511:47 amRNSHolding(s) in Company
13th Nov 20257:00 amRNSQ3 Trading Statement
3rd Nov 202511:43 amRNSTotal Voting Rights
1st Oct 202511:45 amRNSTotal Voting Rights
30th Sep 202512:58 pmRNSDirector/PDMR Shareholding
26th Sep 20255:33 pmRNSHolding(s) in Company
17th Sep 20254:44 pmRNSHolding(s) in Company
9th Sep 202510:14 amRNSDirector/PDMR Shareholding
1st Sep 20252:31 pmRNSTotal Voting Rights
13th Aug 20257:00 amRNSHalf Year Results
1st Aug 202511:36 amRNSTotal Voting Rights
9th Jul 20257:23 amRNSUK CMA proposes closure of its investigation
4th Jul 20251:44 pmRNSHolding(s) in Company
1st Jul 202511:38 amRNSTotal Voting Rights
17th Jun 20253:47 pmRNSHolding(s) in Company
2nd Jun 20253:07 pmRNSBlock listing Interim Review
2nd Jun 202511:39 amRNSTotal Voting Rights
14th May 20257:00 amRNSSale of FibreNest

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.